4//SEC Filing
Zadno Reza 4
Accession 0001628280-24-050224
CIK 0001588978other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:20 PM ET
Size
11.1 KB
Accession
0001628280-24-050224
Insider Transaction Report
Form 4
Zadno Reza
DirectorPresident, CEO
Transactions
- Sale
Common Stock
2024-12-04$96.15/sh−5,300$509,612→ 173,885 total - Sale
Common Stock
2024-12-04$99.04/sh−2,235$221,359→ 152,762 total - Sale
Common Stock
2024-12-04$98.09/sh−5,126$502,808→ 154,997 total - Sale
Common Stock
2024-12-04$97.01/sh−13,762$1,335,065→ 160,123 total
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on August 8, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.65 to $96.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.65 to $97.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.66 to $98.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.97 to $99.47, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Documents
Issuer
PROCEPT BioRobotics Corp
CIK 0001588978
Entity typeother
Related Parties
1- filerCIK 0001632326
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:20 PM ET
- Size
- 11.1 KB